Identification of Rad51 alteration in patients with bilateral breast cancer
スポンサーリンク
概要
- 論文の詳細を見る
- Springer-Verlag Tokyoの論文
- 2000-05-01
著者
-
Sakamoto Goi
Department of Surgery and Pathology, Cancer Institute Hospital
-
Kasumi Fujio
Department of Surgery and Pathology, Cancer Institute Hospital
-
Kato Masahiro
Department of Chemical Engineering, Faculty of Engineering, Kyushu University
-
MIKI Yoshio
Department of Genetic Diagnosis, the Cancer Institute Hospital of JFCR
-
三木 義男
癌研ゲノムセンター
-
Katagiri Toyomasa
京都大学 医学部外科学
-
Katagiri T
Univ. Tokyo Tokyo Jpn
-
Nakamura Yusuke
Human genome center
-
Akiyama Fumihiro
Human Genome Center The Institute Of Medical Science University Of Tokyo
-
Kajiwara Tetsuro
Tochigi Cancer Center Hospital
-
Kodama Tetsuro
栃木県立がんセンター研究所 がん遺伝子研究室
-
NAGAWA Hirokazu
Department of Surgical Oncology, Faculty of Medicine, the University of Tokyo
-
Yoshimoto M
The Cancer Institute Of Japanese Foundation For Cancer Research (jfcr)
-
SAITO Hiroko
Department of Pharmacy and Pharmacokinetics, Aichi Medical University School of Medicine
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
Yoshimoto Masataka
Department of Surgery and Pathology, Cancer Institute
-
Akiyama Futoshi
Department of Surgery and Pathology, Cancer Institute
-
Nakamura Y
東京大学医科学研究所ヒトゲノム解析センター ゲノムシークエンス解析分野
-
Fukino K
Department Of Breast Surgery The Cancer Institute Hospital Of Jfcr
-
Kasumi Fujio
Department Of Breast Surgery Cancer Institute Hospital
-
YANO Ken-ichi
Department of Molecular Diagnosis, Cancer Institute
-
MATSUO Fumie
Department of Molecular Diagnosis, Cancer Institute
-
KATAGIRI Toyomasa
Cancer Genetics Laboratory, Division of Medical and Molecular Genetics, Guy's, King's and St. Thomas
-
KURUMIZAKA Hitoshi
Cellular Signaling Laboratory, The Institute of Physical and Chemical Research (RIKEN)
-
Miki Yoshio
Department Of Clinical Genetic Oncology Cancer Institute Hospital Japanese Foundation For Cancer Res
-
Kasumi Fujio
Department Of Breast Surgery The Cancer Institute Hospital Of Jfcr
-
Sakamoto Goi
Department Of Breast Pathology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Sakamoto Goi
Department Of Breast Pathology Cancer Institute
-
Nagawa Hirokazu
Department Of Surgery Faculty Of Medicine University Of Tokyo
-
Katagiri T
Laboratory Of Molecular Medicine Human Genome Center Institute Of Medical Science University Of Toky
-
Matsuo Fumie
Department Of Molecular Diagnosis Cancer Institute
-
Saito Hiroko
Department Of Molecular Diagnosis Cancer Institute
-
Yano Ken-ichi
Department Of Molecular Diagnosis Cancer Institute
-
Akiyama Futoshi
Division Of Pathology Cancer Institute Of Japanese Foundation For Cancer Research
-
Akiyama Futoshi
Department Of Breast Pathology Cancer Institute And Hospital Japanese Foundation For Cancer Research
-
Kurumizaka Hitoshi
Cellular Signaling Laboratory The Institute Of Physical And Chemical Research (riken)
-
Saito Hiroko
Department Of Biological Mechanisms And Functions Graduate School Of Bioagricultural Sciences Nagoya
-
Nakamura Yusuke
Univ. Tokyo Tokyo Jpn
-
Kato Masahiro
Department Of Botany National Museum Of Nature And Science
-
Nakamura Yusuke
Laboratory Of Molecular Medicine Human Genome Center Institute Of Medical Science University Of Toky
-
Nagawa Hirokazu
Department Of Surgery Division Of Surgical Oncology University Of Tokyo
-
Saito Hiroko
Department Of Human Genome Analysis Cancer Institute
-
Kato Masahiro
Department Of Biological Sciences Graduate School Of Science University Of Tokyo
-
Kato Masahiro
Department Of Molecular Diagnosis Cancer Institute
-
Kato Masahiro
Department Of Analytical Chemistry Meiji College Of Pharmacy:faculty Of Pharmaceutical Sciences Chib
-
Yoshimoto Masataka
Department Of Molecular Diagnosis Cancer Institute Japanese Foundation For Cancer Research
関連論文
- ゲノム情報を生かした個別化医療 (特集 固形癌の最新治療--癌治療への新たな取り組み) -- (治療の新たな取り組み 個別化治療)
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Overrepresentation of the EBAG9 Gene at 8q23 Associated with Early-Stage Breast Cancers
- Preparation of artificial skeletal muscle tissues by a magnetic force-based tissue engineering technique(CELL AND TISSUE ENGINEERING)
- Recurrence Pattern and Rapid Intraoperative Detection of Carcinoembryonic Antigen (CEA) mRNA in Pleural Lavage in Patients with Non-Small Cell Lung Cancer (NSCLC)
- P-674 大腸癌肝転移切除例のSurgical Marginについての遺伝子学的および組織学的検討
- PP-1137 大腸癌肝転移に対する外科的治療戦略 : Surgical Marginについての遺伝子学的および臨床病理学的検討
- A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene